Evidence map›Paper›PMID 31363187›Full record

ArticleEuropean journal of human genetics : EJHG2019

Current management of transition of young people affected by rare renal conditions in the ERKNet.

Martin Kreuzer, Jens Drube, Jenny Prüfe, Franz Schaefer, Lars Pape, Members of the ERKNet Taskforce ‘QoL & Transition’

Abstract read
In one paragraph

Article in European journal of human genetics : EJHG, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. [The European Rare Kidney Disease Reference Network].Innere Medizin (Heidelberg, Germany) · 2024
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Martin KreuzerDepartment of Paediatric Nephrology, Hepatology & Metabolic Diseases, Hannover Medical School, Hannover, Germany. kreuzer.martin@mh-hannover.de.
Jens DrubeDepartment of Paediatric Nephrology, Hepatology & Metabolic Diseases, Hannover Medical School, Hannover, Germany.
Jenny PrüfeDepartment of Paediatric Nephrology, Hepatology & Metabolic Diseases, Hannover Medical School, Hannover, Germany.
Franz SchaeferDepartment of Paediatrics I, University Children's Hospital, Heidelberg, Germany.
Lars PapeDepartment of Paediatric Nephrology, Hepatology & Metabolic Diseases, Hannover Medical School, Hannover, Germany.
Members of the ERKNet Taskforce ‘QoL & Transition’

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Transition in medical care is a high-risk period in adolescence and young adulthood. To date, data on transition policy, its application in practice, and transition procedures in patients with rare, hereditary kidney diseases in Europe is scarce. An online survey was developed and was distributed within the paediatric centres of the European Reference Network for Rare Kidney Diseases (ERKNet) aiming to assess the transition-relevant structures from the providers' perspectives. Its items were based on the consensus statement on transition published by the International Society of Nephrology (ISN) and the International Paediatric Nephrology Association (IPNA) in 2011. Forty-six paediatric experts based at 28/32 ERKNet university hospitals participated. Annually, a median number of 14 patients (1-80) are transferred to adult based care. One centre continued to care for paediatric kidney transplant recipients throughout their entire lifespan. Choosing this option terminated the survey and no further data was obtained from this centre. 29/45 experts confirmed the application of an-at least unwritten-transition procedure (64%). Transition clinics are offered by 23 experts. Most physicians (40%) transfer patients at age 18-19, 10 experts at age <18. Most physicians transfer the patients to a university hospital and/or a community hospital. The transition guidelines have been implemented in ERKNet centres only partly and with huge heterogeneity. Implementation of transition tools and structures within ERKNet could improve health of children with hereditary kidney diseases. Adherence of experts to the transition-guidelines was significantly correlated with gross national income of their countries.

Indexed as

AdolescentAdultChildEuropeFemaleHumansKidneyKidney DiseasesMaleNephrologyRare DiseasesYoung Adult

Identifiers

PMID31363187
PMCPMC6871530

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.